Literature DB >> 9065528

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

F D Lublin1, S C Reingold.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  1997        PMID: 9065528     DOI: 10.1212/wnl.48.3.572

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

Review 1.  Neurological rehabilitation: from mechanisms to management.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

2.  Clinically isolated syndrome and multiple sclerosis: rethinking the arsenal.

Authors:  Krupa Pandey; Fred D Lublin
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

3.  Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.

Authors:  Hasan Simsek; Hikmet Geckin; Nilay Padir Sensoz; Edward O List; Ahmet Arman
Journal:  J Mol Neurosci       Date:  2018-11-16       Impact factor: 3.444

4.  Prevalence of sea, seb, sec, sed, and tsst-1 genes of Staphylococcus aureus in nasal carriage and their association with multiple sclerosis.

Authors:  Zahra Pakbaz; Mohammad Ali Sahraian; Samira Sabzi; Mahmood Mahmoodi; Mohammad Reza Pourmand
Journal:  Germs       Date:  2017-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.